Funder
National Institutes of Health
NIMH
Vanderbilt Kennedy Center
Reference40 articles.
1. Once-weekly semaglutide in adults with overweight or obesity;Wilding;N. Engl. J. Med.,2021
2. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial;O'Neil;Lancet,2018
3. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity;Blundell;Diabetes Obes. Metab.,2017
4. Controlled trial of 3.0 mg of liraglutide in weight management;Pi-Sunyer;N. Engl. J. Med.,2015
5. Controlled trial of liraglutide for adolescents with obesity;Kelly;N. Engl. J. Med.,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献